FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to the chemical-pharmaceutical industry, and relates to method for evaluating the biological activity of a tetradecapeptide consisting of 14 amino acid residues, of the general formula TEKKRRETVEREKE (TDP). Method for evaluating the biological activity of a TDP is that the test peptide is added to the culture of 3T3/NIH fibroblast cells in vitro followed by incubating the resulting mixture for 5 minutes and determining the degree of phosphorylation of the ERK1/2 kinase by fluorescence microscopy or by immunoblotting.
EFFECT: method for evaluating the biological activity of TDP is proposed.
1 cl, 2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TORK PROTEIN KINASE INHIBITOR WITH DIRECTED CHEMOPREVENTIVE EFFECT IN VITRO | 2014 |
|
RU2566268C1 |
| METHOD FOR DETERMINING THE WOUND-HEALING ACTIVITY OF SAMPLES OF PRODUCTS OF SUPERCRITICAL EXTRACTION OF PLANT RAW MATERIALS FOR USE AS WOUND-HEALING DRUGS IN VITRO | 2021 |
|
RU2781306C1 |
| EZRIN DERIVATIVES PEPTIDES AND PHARMACEUTICAL COMPOSITIONS BASED THEREON | 2016 |
|
RU2694906C2 |
| CARDIOTROFIN APPLICATION IN LIVER DISEASES | 2002 |
|
RU2279289C2 |
| METHOD OF TREATING ABNORMAL CELL EXPANSION | 2006 |
|
RU2384331C2 |
| METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2 PLASMA LEVELS | 2014 |
|
RU2687097C2 |
| METHOD OF PROVIDING REQUIRED LEVELS OF GLIAL GROWTH FACTOR 2 IN PLASMA | 2009 |
|
RU2530650C2 |
| THERAPEUTIC COMPOSITION FOR REDUCING RESISTANCE TO TYROSINE KINASE INHIBITORS | 2016 |
|
RU2735493C2 |
| SOLID SALT FORMS OF PYRROLE-SUBSTITUTED 2-INDOLINONE | 2006 |
|
RU2399619C2 |
| CULTURE MEDIUM FOR EPITHELIAL CELLS OF LARYNGEAL CANCER, METHOD OF CULTIVATION AND USE THEREOF | 2020 |
|
RU2814719C1 |
